Winterflood reveals top healthcare and biotech picks as sentiment improves one year after US election

Turnaround in the sector

Trust analysts at Winterflood have highlighted their favoured biotech and healthcare trusts, as the sector continues its comeback after the threat of significant political reform was reduced following Donald Trump's win in the US Presidential Election a year ago.

The average discount for the AIC's Biotechnology and Healthcare sector has tightened from a weighted average of 5% a year ago to 0% today, while all but one of the funds in existence for more than a year (BB Healthcare was only launched in December) have outperformed the MSCI World Health Care index, which rose 12.8% over one year to 2 November. Over the period, the biggest riser was the £1.2bn Worldwide Healthcare trust, up 32% in share price terms, followed by sister company Biotech Growth trust, up 26%, according to the analysts. This compares to a smaller rise of 7% and a loss of ...